Literature DB >> 24611172

Polio: The eradication endgame.

Cassandra Willyard.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24611172     DOI: 10.1038/507s14a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.

Authors:  Cara C Burns; Jing Shaw; Jaume Jorba; David Bukbuk; Festus Adu; Nicksy Gumede; Muhammed Ali Pate; Emmanuel Ade Abanida; Alex Gasasira; Jane Iber; Qi Chen; Annelet Vincent; Paul Chenoweth; Elizabeth Henderson; Kathleen Wannemuehler; Asif Naeem; Rifqiyah Nur Umami; Yorihiro Nishimura; Hiroyuki Shimizu; Marycelin Baba; Adekunle Adeniji; A J Williams; David R Kilpatrick; M Steven Oberste; Steven G Wassilak; Oyewale Tomori; Mark A Pallansch; Olen Kew
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

2.  Priming after a fractional dose of inactivated poliovirus vaccine.

Authors:  Sonia Resik; Alina Tejeda; Roland W Sutter; Manuel Diaz; Luis Sarmiento; Nilda Alemañi; Gloria Garcia; Magilé Fonseca; Lai Heng Hung; Anna-Lea Kahn; Anthony Burton; J Mauricio Landaverde; R Bruce Aylward
Journal:  N Engl J Med       Date:  2013-01-31       Impact factor: 91.245

3.  The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting.

Authors:  Tara D Mangal; R Bruce Aylward; Nicholas C Grassly
Journal:  Am J Epidemiol       Date:  2013-10-07       Impact factor: 4.897

  3 in total
  2 in total

Review 1.  The prevention and eradication of smallpox: a commentary on Sloane (1755) 'An account of inoculation'.

Authors:  Robin A Weiss; José Esparza
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-19       Impact factor: 6.237

Review 2.  The dichotomy of pathogens and allergens in vaccination approaches.

Authors:  Fiona J Baird; Andreas L Lopata
Journal:  Front Microbiol       Date:  2014-07-16       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.